In accordance, BC TCGA data analysis revealed that high OXER1 expression correlated with estrogen- (ER) and progesterone receptors (PR) status, suggesting that OXER1 is a new and attractive target for pharmacological intervention. The gene discussed is PGR; the disease is breast cancer.